Engineering the matrix microenvironment for cell delivery and engraftment for tissue repair

Current Opinion in Biotechnology

Volumn 24, Issue 5, 2013, Pages 864-871

  Cheng, Amy Y ^a   García, Andrés J ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DELIVERY; CELL THERAPY; CELL-BASED THERAPY; CURRENT CELLS; ENGRAFTMENT; MICROENVIRONMENTS; TISSUE REPAIR; TRANSPLANTED CELLS;

CELLS; CYTOLOGY; DISEASE CONTROL; REPAIR;

CELL ENGINEERING;

INTEGRIN;

BIODEGRADABILITY; CELL ADHESION; CELL ENGINEERING; CELL FATE; CELL THERAPY; CELLULAR PARAMETERS; ENGRAFTMENT; EXTRACELLULAR MATRIX; HUMAN; LIGAND BINDING; MATRIX STIFFNESS; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; TISSUE REPAIR; VASCULARIZATION;

EID: 84884415227     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.04.005     Document Type: Review

References (58)

1. Malliaras K., Kreke M., Marban E. The stuttering progress of cell therapy for heart disease. Clin Pharmacol Ther 2011, 90:532-541.
2. Hou D., Youssef E.A., Brinton T.J., Zhang P., Rogers P., Price E.T., Yeung A.C., Johnstone B.H., Yock P.G., March K.L. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112:I150-I156.
3. Shear D.A., Tate C.C., Tate M.C., Archer D.R., LaPlaca M.C., Stein D.G., Dunbar G.L. Stem cell survival and functional outcome after traumatic brain injury is dependent on transplant timing and location. Restor Neurol Neurosci 2011, 29:215-225.
4. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106:1570-1581.
5. Terrovitis J., Lautamaki R., Bonios M., Fox J., Engles J.M., Yu J., Leppo M.K., Pomper M.G., Wahl R.L., Seidel J., et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 2009, 54:1619-1626.
6. Quevedo H.C., Hatzistergos K.E., Oskouei B.N., Feigenbaum G.S., Rodriguez J.E., Valdes D., Pattany P.M., Zambrano J.P., Hu Q., McNiece I., et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 2009, 106:14022-14027.
7. Stabenfeldt S.E., Munglani G., García A.J., LaPlaca M.C. Biomimetic microenvironment modulates neural stem cell survival, migration, and differentiation. Tissue Eng Part A 2010, 16:3747-3758.
8. Kim S., Kim S.S., Lee S.H., Eun Ahn S., Gwak S.J., Song J.H., Kim B.S., Chung H.M. In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Biomaterials 2008, 29:1043-1053.
9. Levi B., Hyun J.S., Montoro D.T., Lo D.D., Chan C.K., Hu S., Sun N., Lee M., Grova M., Connolly A.J., et al. In vivo directed differentiation of pluripotent stem cells for skeletal regeneration. Proc Natl Acad Sci U S A 2012.
10. Hunter K.T., Ma T. In vitro evaluation of hydroxyapatite-chitosan-gelatin composite membrane in guided tissue regeneration. J Biomed Mater Res A 2012.
11. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., Hubbell J.A. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003, 21:513-518.
12. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
13. Discher D.E., Janmey P., Wang Y.L. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
14. Trappmann B., Gautrot J.E., Connelly J.T., Strange D.G., Li Y., Oyen M.L., Cohen Stuart M.A., Boehm H., Li B., Vogel V., et al. Extracellular-matrix tethering regulates stem-cell fate. Nat Mater 2012, 11:642-649.
15. Connelly J.T., Gautrot J.E., Trappmann B., Tan D.W., Donati G., Huck W.T., Watt F.M. Actin and serum response factor transduce physical cues from the microenvironment to regulate epidermal stem cell fate decisions. Nat Cell Biol 2010, 12:711-718.
16. Gao L., McBeath R., Chen C.S. Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin. Stem Cells 2010, 28:564-572.
17. Huebsch N., Arany P.R., Mao A.S., Shvartsman D., Ali O.A., Bencherif S.A., Rivera-Feliciano J., Mooney D.J. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 2010, 9:518-526.
18. Bott K., Upton Z., Schrobback K., Ehrbar M., Hubbell J.A., Lutolf M.P., Rizzi S.C. The effect of matrix characteristics on fibroblast proliferation in 3D gels. Biomaterials 2010, 31:8454-8464.
19. Bian L., Hou C., Tous E., Rai R., Mauck R.L., Burdick J.A. The influence of hyaluronic acid hydrogel crosslinking density and macromolecular diffusivity on human MSC chondrogenesis and hypertrophy. Biomaterials 2013, 34:413-421.
20. Phelps E.A., Enemchukwu N.O., Fiore V.F., Sy J.C., Murthy N., Sulchek T.A., Barker T.H., García A.J. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv Mater 2012, 24:64-70. 62.
21. Ghajar C.M., Chen X., Harris J.W., Suresh V., Hughes C.C., Jeon N.L., Putnam A.J., George S.C. The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J 2008, 94:1930-1941.
22. Lutolf M.P., Raeber G.P., Zisch A.H., Tirelli N., Hubbell J.A. Cell-responsive synthetic hydrogels. Adv Mater 2003, 15:888-892.
23. Boerckel J.D., Kolambkar Y.M., Dupont K.M., Uhrig B.A., Phelps E.A., Stevens H.Y., García A.J., Guldberg R.E. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 2011, 32:5241-5251.
24. Geuze R.E., Theyse L.F., Kempen D.H., Hazewinkel H.A., Kraak H.Y., Oner F.C., Dhert W.J., Alblas J. A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model. Tissue Eng Part A 2012, 18:2052-2062.
25. Sakiyama-Elbert S.E., Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000, 65:389-402.
26. Taylor S.J., McDonald J.W., Sakiyama-Elbert S.E. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release 2004, 98:281-294.
27. Phelps E.A., Landazuri N., Thule P.M., Taylor W.R., García A.J. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci U S A 2010, 107:3323-3328.
28. Degano I.R., Vilalta M., Bago J.R., Matthies A.M., Hubbell J.A., Dimitriou H., Bianco P., Rubio N., Blanco J. Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials 2008, 29:427-437.
29. Becquart P., Cambon-Binder A., Monfoulet L.E., Bourguignon M., Vandamme K., Bensidhoum M., Petite H., Logeart-Avramoglou D. Ischemia is the prime but not the only cause of human multipotent stromal cell death in tissue-engineered constructs in vivo. Tissue Eng Part A 2012, 18:2084-2094.
30. Ehrbar M., Zeisberger S.M., Raeber G.P., Hubbell J.A., Schnell C., Zisch A.H. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 2008, 29:1720-1729.
31. Moon J.J., Saik J.E., Poche R.A., Leslie-Barbick J.E., Lee S.H., Smith A.A., Dickinson M.E., West J.L. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010, 31:3840-3847.
32. Kanczler J.M., Ginty P.J., Barry J.J., Clarke N.M., Howdle S.M., Shakesheff K.M., Oreffo R.O. The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials 2008, 29:1892-1900.
33. Jabbarzadeh E., Starnes T., Khan Y.M., Jiang T., Wirtel A.J., Deng M., Lv Q., Nair L.S., Doty S.B., Laurencin C.T. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proc Natl Acad Sci U S A 2008, 105:11099-11104.
34. Lieberman J.R., Daluiski A., Stevenson S., Wu L., McAllister P., Lee Y.P., Kabo J.M., Finerman G.A., Berk A.J., Witte O.N. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 1999, 81:905-917.
35. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000, 102:898-901.
36. Miller J.S., Stevens K.R., Yang M.T., Baker B.M., Nguyen D.H., Cohen D.M., Toro E., Chen A.A., Galie P.A., Yu X., et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater 2012, 11:768-774.
37. Hynes R.O. Integrins bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
38. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002, 23:4315-4323.
39. Wang L., Stegemann J.P. Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering. Biomaterials 2010, 31:3976-3985.
40. Masters K.S., Shah D.N., Leinwand L.A., Anseth K.S. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 2005, 26:2517-2525.
41. Benoit D.S., Schwartz M.P., Durney A.R., Anseth K.S. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 2008, 7:816-823.
42. Reyes C.D., García A.J. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide. J Biomed Mater Res A 2003, 65:511-523.
43. Reyes C.D., Petrie T.A., Burns K.L., Schwartz Z., García A.J. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 2007, 28:3228-3235.
44. Shekaran A., García A.J. Extracellular matrix-mimetic adhesive biomaterials for bone repair. J Biomed Mater Res A 2011, 96:261-272.
45. Keselowsky B.G., Collard D.M., García A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 2005, 102:5953-5957.
46. Kim J., Kim I.S., Cho T.H., Kim H.C., Yoon S.J., Choi J., Park Y., Sun K., Hwang S.J. In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J Biomed Mater Res A 2010, 95:673-681.
47. Aota S., Nomizu M., Yamada K.M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 1994, 269:24756-24761.
48. Petrie T.A., Raynor J.E., Reyes C.D., Burns K.L., Collard D.M., García A.J. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration. Biomaterials 2008, 29:2849-2857.
49. Hennessy K.M., Clem W.C., Phipps M.C., Sawyer A.A., Shaikh F.M., Bellis S.L. The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials 2008, 29:3075-3083.
50. Miyamoto S. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol 1996, 135:1633-1642.
51. Martino M.M., Tortelli F., Mochizuki M., Traub S., Ben-David D., Kuhn G.A., Muller R., Livne E., Eming S.A., Hubbell J.A. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med 2011, 3:100ra189.
52. Petrie T.A., Raynor J.E., Dumbauld D.W., Lee T.T., Jagtap S., Templeman K.L., Collard D.M., García A.J. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci Transl Med 2010, 2:45-60.
53. Rossello R.A., Wang Z., Kizana E., Krebsbach P.H., Kohn D.H. Connexin 43 as a signaling platform for increasing the volume and spatial distribution of regenerated tissue. Proc Natl Acad Sci U S A 2009, 106:13219-13224.
54. Kloxin A.M., Kasko A.M., Salinas C.N., Anseth K.S. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 2009, 324:59-63.
55. Wirkner M., Weis S., San Miguel V., Alvarez M., Gropeanu R.A., Salierno M., Sartoris A., Unger R.E., Kirkpatrick C.J., del Campo A. Photoactivatable caged cyclic RGD peptide for triggering integrin binding and cell adhesion to surfaces. Chembiochem 2011, 12:2623-2629.
56. Salimath A.S., Phelps E.A., Boopathy A.V., Che P.L., Brown M., García A.J., Davis M.E. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS ONE 2012, 7:e50980.
57. Pashuck E.T., Stevens M.M. Designing regenerative biomaterial therapies for the clinic. Sci Transl Med 2012, 4:160sr164.
58. Jaklenec A., Stamp A., Deweerd E., Sherwin A., Langer R. Progress in the tissue engineering and stem cell industry "are we there yet?". Tissue Eng Part B Rev 2012, 18:155-166.